One sample, two targets. Simultaneous detection of human immunodeficiency virus (HIV, an RNA virus) and Treponema pallidum (TP, the DNA pathogen responsible for syphilis) addresses a key need in STI research workflows.

A study published in ACS Sensors demonstrates a single-tube platform integrating reverse transcription, recombinase polymerase amplification (RPA), in vitro transcription (IVT), and CRISPR detection using Cas12a and Cas13a. This fully isothermal system runs at 37°C. Coupled with a press-actuated plasma separation chip and smartphone readout, the research platform generates results from whole blood in under 30 minutes.

Figure 1. Duplex detection workflow, from whole-blood processing and a single-step CRISPR reaction to incubation and smartphone-based interpretation.

Figure 1. Duplex detection workflow, from whole-blood processing and a single-step CRISPR reaction to incubation and smartphone-based interpretation.

The challenge extends beyond designing CRISPR RNA (crRNA). Several enzymes must work together in one tube, at one temperature, while maintaining two distinguishable detection channels. That makes enzyme compatibility and formulation central to the design.

Two Channels That Share One Reaction

The assay brings several reactions into the same tube while keeping the HIV RNA signal separate from the TP DNA signal. Rather than relying on fluorescence barcoding or physically separated compartments, it uses the different substrate preferences of Cas12a and Cas13a: Cas12a recognizes DNA and cleaves a single-stranded DNA reporter, while Cas13a recognizes RNA and cleaves a single-stranded RNA reporter.

In the HIV channel, reverse transcription converts RNA into cDNA, RPA amplifies the resulting DNA, and Cas12a activates a green FAM reporter. In the TP channel, RPA introduces a T7 promoter; IVT then generates an RNA target that activates Cas13a and a red ROX reporter.

Both channels share the 37°C reaction. The press-actuated chip avoids a separate nucleic acid extraction step: a plasma-separation membrane removes blood-associated inhibitors, and the filtrate directly reconstitutes the lyophilized reagents.

Figure 2. Separate HIV and TP signaling pathways within the single-step duplex RPA–CRISPR system.

Figure 2. Separate HIV and TP signaling pathways within the single-step duplex RPA–CRISPR system.

Give Each Enzyme a Clear Role

Following the reaction from template to signal makes the demands on each enzyme easier to see. The enzymes share a tube, but they do different jobs and face different constraints.

Reverse Transcriptase Connects the RNA Target to Amplification

The reverse transcriptase in the HIV channel must function at 37 °C in a complex one-pot mixture, rather than under a conventional RT-qPCR workflow. Useful properties include efficient reverse transcription, suppressed RNase H activity, and a low-glycerol formulation that is compatible with lyophilization. In this setting, stability matters alongside activity: a higher-mass-concentration enzyme preparation can help support rapid initiation while limiting premature template consumption.

Figure 3. Conceptual reverse transcriptase comparison. The illustration contrasts RNase H activity and performance with structured RNA; its 37 °C and 50 °C labels are illustrative comparisons, not the duplex assay’s reaction program.

Figure 3. Conceptual reverse transcriptase comparison. The illustration contrasts RNase H activity and performance with structured RNA; its 37 °C and 50 °C labels are illustrative comparisons, not the duplex assay’s reaction program.

RPA Depends on Its Core Enzymes and Supporting Chemistry

RPA uses recombinases to support unwinding and amplification without thermocycling. The balance among UvsX, UvsY, gp32, and Bsu polymerase is important for amplification. UvsX consumes ATP, so a creatine kinase–phosphocreatine ATP-regeneration system supplies continued energy. Fluorescence-based systems may also include Exonuclease III.

Tris, potassium salts, polyethylene glycol (PEG), DTT, and magnesium ions also influence reaction initiation. Conventional commercial enzymes can contain substantial glycerol, which complicates freeze-drying. Glycerol-free or low-glycerol enzyme preparations are therefore preferred for a lyophilized one-pot system.

Figure 4. RPA mechanism, showing recombinase–primer complex formation, strand invasion, single-stranded DNA binding proteins, and strand-displacing polymerase activity.

Figure 4. RPA mechanism, showing recombinase–primer complex formation, strand invasion, single-stranded DNA binding proteins, and strand-displacing polymerase activity.

T7 RNA Polymerase Supplies the Second RNA Target

TP contributes a DNA target, whereas Cas13a recognizes RNA. A T7 promoter introduced through the RPA primers allows T7 RNA polymerase to transcribe the amplified DNA in the same reaction, producing RNA for Cas13a detection.

T7 RNA polymerase must remain productive at 37°C in the shared multi-enzyme mixture. Excessive transcription can compete for the ribonucleoside triphosphate (rNTP) pool and raise background; insufficient transcription leaves too little RNA target. A T7 preparation with low double-stranded RNA (dsRNA) by-product formation and consistent batch performance is more useful here than simply maximizing activity.

Cas12a Turns Recognition into Reporter Cleavage

crRNA guides Cas12a to its DNA target. Once activated, Cas12a can cleave nearby single-stranded DNA reporters through collateral, or trans, cleavage, generating multiple reporter-cleavage events from target recognition.

One-pot reactions also expose an important tradeoff: Cas-mediated cis cleavage can consume the original target before enough amplification product accumulates. The source article discusses crRNA recognition-site design and enzyme selection as ways to manage this competition. Cas specific activity, cleavage preference, and batch consistency all influence reproducibility.

Figure 5. Cas12a target recognition and cleavage, including PAM recognition, R-loop formation, and cleavage of target and non-target strands.

Figure 5. Cas12a target recognition and cleavage, including PAM recognition, R-loop formation, and cleavage of target and non-target strands.

RNase Inhibitor Protects the Shared RNA Pool

The reaction contains an RNA target, reverse-transcription products, and T7-generated RNA. Even small amounts of RNase contamination can compromise the RNA channel. RNase inhibitor is a common protective component, with glycerol-free versions preferred for lyophilized formulations. These supporting reagents are used in modest amounts, yet they can contribute substantially to batch variation and failures outside the laboratory.

A Research Assay Still Needs a Product Formulation

The reported system remains at the laboratory research stage, although its intended product format is clear: lyophilized single-tube reagents, a press-actuated chip, and smartphone-based interpretation. Freeze-drying and reliable reconstitution are major development hurdles.

Lyophilization depends on the buffer system, enzyme loading, residual glycerol, protective excipients, freeze-drying cycle, residual moisture, and reconstitution behavior. The high protein and PEG content of RPA mixtures can contribute to cake collapse, foaming or material ejection, and activity loss. Product development also requires validation of batch consistency, transport stability, accelerated aging, and the applicable registration requirements.

Supply at scale brings another set of demands. Research can begin with carefully selected enzyme lots; commercialization needs controlled enzyme variability, predictable manufacturing capacity and cost, and continuous supply. Because the activities of several enzymes must be matched, changing a supplier can require renewed formulation work. This is one reason teams often develop enzyme raw materials and the freeze-drying process with the same upstream partner.

From Duplex Screening to Broader Panels

Potential settings include reproductive-health clinics, antenatal screening, preoperative testing, blood-donation screening, primary care, and border checkpoints, where fast turnaround and portable equipment are useful.

The same principle of substrate-orthogonal Cas detection could support respiratory, fever, or gastrointestinal syndrome panels. The technical approach may also extend to veterinary testing for African swine fever, pesticide-residue testing, food safety, and field biosafety testing. Each application still needs joint optimization of the enzyme supply and assay formulation around isothermal operation and lyophilization before product deployment.

YEASEN Raw Materials for RPA and CRISPR Development

YEASEN supports development from individual enzymes to premixes and lyophilized formats. Formats include DNA and RNA rapid isothermal amplification kits and individual RPA components.

Product category

Product name

Cat. No.

RPA premixes

DNA Rapid Isothermal Amplification Kit (Fluorescent)

16702ES/16904ES

RNA Rapid Isothermal Amplification Kit (Fluorescent)

16708ES/16905ES

DNA Rapid Isothermal Amplification Kit (Chromatographi)

16725ES/16906ES

RNA Rapid Isothermal Amplification Kit (Chromatographi)

16726ES/16907ES

DNA Rapid Isothermal Amplification Kit (Basic)

16727ES/16908ES

RNA Rapid Isothermal Amplification Kit (Basic)

16728ES/16909ES

RPA enzymes

T4 UvsX Recombinase (2 µg/µL)

11079ES

T4 UvsY protein (2 µg/µL)

11080ES

T4 Gene 32 Protein (gp32, 10 µg/µL)

14414ES

T4 Gene 32 Protein gp32 (5 µg/µL)

11081ES

Bsu DNA Polymerase (Large fragment, 50 U/µL)

14415ES

Bsu DNA Polymerase (Large fragment, 5 U/µL)

11078ES

Creatine Kinase (2 µg/µL)

14502ES

Exonuclease III (100 U/µL)

14525ES

2× RPA Amplification Buffer (Universal RPA Buffer)

16928ES

Reverse transcriptases

Hifair UCF. ME™ Advanced Reverse Transcriptase, Glycerol-free (200 U/µL)

14617ES

Hifair™ V Reverse Transcriptase (600 U/µL, Glycerol-free)

11301ES

T7 RNA polymerases

T7 RNA Polymerase (250 U/µL)

10626ES

T7 RNA Polymerase GMP-grade (50 U/µL)

10624ES

T7 RNA Polymerase GMP-grade (250 U/µL)

10625ES

Hieff™ T7 RNA Polymerase GMP-grade (low dsRNA, 250 U/µL)

10629ES

T7 High Yield RNA Synthesis Kit (low dsRNA)

10633ES

Cas proteins

ArCas12a Nuclease (10 µM)

14702ES

AapCas12b Nuclease (10 µM)

14808ES

RNase inhibitor

Murine RNase Inhibitor (200 U/µL, Glycerol-free)

10703ES

Reference

Xu Z, et al. Integrated Single-Step Duplex CRISPR-Based System for Point-of-Care Detection of Human Immunodeficiency Virus and Treponema pallidum Directly from Whole Blood. ACS Sensors. 2026. DOI: 10.1021/acssensors.6c01767.

जाँच करना